Used as a key intermediate in the synthesis of fluorinated pharmaceuticals, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports binding to enzyme active sites, enhancing selectivity and potency. Also employed in the preparation of bioactive molecules where fluorine substitution improves metabolic stability and membrane permeability. Commonly utilized in research settings for designing new drug candidates targeting neurological and oncological pathways.